-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $55

Benzinga·09/18/2026 12:56:46
Listen to the news
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $62 to $55.